Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.
CONCLUSION: Genetic polymorphisms in the MMR pathway are potential clinical markers for predicting chemotherapy toxicity in NSCLC patients.
PMID: 28093084 [PubMed - in process]
Source: Chinese Journal of Cancer - Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Gastroschisis Repair | Genetics | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Study | Toxicology